• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Carlsmed

    Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance
    From Carlsmed
    Via GlobeNewswire
    Tickers CARL
    Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025
    From Carlsmed
    Via GlobeNewswire
    Tickers CARL
    Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary
    From Carlsmed
    Via GlobeNewswire
    Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index
    From Carlsmed
    Via GlobeNewswire
    UPDATE - Carlsmed® Reports Second Quarter 2025 Financial Results
    From Carlsmed
    Via GlobeNewswire
    Carlsmed® Reports Second Quarter 2025 Financial Results
    From Carlsmed
    Via GlobeNewswire
    Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025
    From Carlsmed
    Via GlobeNewswire
    Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures
    From Carlsmed
    Via GlobeNewswire
    Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery
    From Carlsmed
    Via GlobeNewswire
    Carlsmed Announces Filing of Registration Statement for Proposed Initial Public Offering
    From Carlsmed
    Via Business Wire
    Carlsmed Launches Cutting-Edge Digital Production Line, Revolutionizing Spine Surgery
    From Carlsmed
    Via Business Wire
    Carlsmed Adds Industry Veteran, Kevin O’Boyle, to Board of Directors
    From Carlsmed
    Via Business Wire
    Carlsmed Announces Favorable Medicare Reimbursement Decision for Spinal Fusions with Custom-Made Anatomically Designed Devices
    From Carlsmed
    Via Business Wire
    Carlsmed Raises $52.5M in Series C Financing to Advance Personalized Spine Surgery
    From Carlsmed
    Via Business Wire
    Compelling Clinical Data Released for Carlsmed’s aprevo® Technology
    From Carlsmed
    Via Business Wire
    FDA Grants Second Breakthrough Device Designation for Carlsmed Technology
    From Carlsmed
    Via Business Wire
    COMPaSS™ Personalized Spine Surgery Study Begins Enrollment
    From Carlsmed
    Via Business Wire
    Carlsmed Raises $30M in Series B Funding to Scale Personalized Spine Surgery
    From Carlsmed
    Via Business Wire
    CMS Grants Transitional Pass-Through (TPT) Payment for Carlsmed's aprevo® Personalized Interbody Devices
    From Carlsmed
    Via Business Wire
    Carlsmed aprevo® Wins Spine Technology Award
    From Carlsmed
    Via Business Wire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.